CIK 0001991792
- Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371611499
- Phone
- +1 949-409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $2,665,586
- in 2 filings
- Open-market sales, last 90 days
- $227,045
- in 3 filings, $227K under 10b5-1 plans
Net +$2,438,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-18 | Kalofonos Isabel Chief Commercial Officer | Purchase | +3,751 | $79.76 | $299K | 3,751 |
| 2026-10-15 | Kalofonos Isabel Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +92,000 | 92,000 |
Page 1 of 1 · 2 trades